Search research articles
Contact Us
Filters
Showing results (761-770 of 1,211) with videos related to
Page
of 122
Sort By:
European Journal of Heart Failure
|
November 17, 2022
Health-related quality of life outcomes in PARAGON-HF
Alvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
European Heart Journal
|
June 26, 2023
Stroke in patients with heart failure and reduced or preserved ejection fraction
Mingming Yang, Toru Kondo, Jawad H Butt, et al.
European Heart Journal
|
May 28, 2026
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis
Ryohei Ono, Misato Chimura, Kieran F Docherty, et al.
Journal of the American College of Cardiology
|
January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women
Pooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF
James P Curtain, Alice M Jackson, Li Shen, et al.
Circulation. Heart Failure
|
May 18, 2019
Rationale and Design of the VITALITY-HFpEF Trial
Javed Butler, Carolyn S P Lam, Kevin J Anstrom, et al.
Journal of the American College of Cardiology
|
March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function
Iris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
The New England Journal of Medicine
|
November 18, 2024
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
Marianna Fontana, Scott D Solomon, Jessica Kachadourian, et al.
Journal of the American College of Cardiology
|
September 25, 2024
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF
Shingo Matsumoto, Li Shen, Alasdair D Henderson, et al.
European Journal of Heart Failure
|
June 27, 2024
Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF
Mats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
Page
of 122
Search research articles
Search
Showing results (761-770 of 1,211) with videos related to
Sort By:
Page
of 122
European Journal of Heart Failure
|
November 17, 2022
Health-related quality of life outcomes in PARAGON-HF
Alvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
European Heart Journal
|
June 26, 2023
Stroke in patients with heart failure and reduced or preserved ejection fraction
Mingming Yang, Toru Kondo, Jawad H Butt, et al.
European Heart Journal
|
May 28, 2026
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis
Ryohei Ono, Misato Chimura, Kieran F Docherty, et al.
Journal of the American College of Cardiology
|
January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women
Pooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF
James P Curtain, Alice M Jackson, Li Shen, et al.
Circulation. Heart Failure
|
May 18, 2019
Rationale and Design of the VITALITY-HFpEF Trial
Javed Butler, Carolyn S P Lam, Kevin J Anstrom, et al.
Journal of the American College of Cardiology
|
March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function
Iris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
The New England Journal of Medicine
|
November 18, 2024
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
Marianna Fontana, Scott D Solomon, Jessica Kachadourian, et al.
Journal of the American College of Cardiology
|
September 25, 2024
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF
Shingo Matsumoto, Li Shen, Alasdair D Henderson, et al.
European Journal of Heart Failure
|
June 27, 2024
Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF
Mats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
Page
of 122